In situ quantification of HER2–protein tyrosine kinase 6 (PTK6) protein–protein complexes in paraffin sections from breast cancer tissues

por Aubele, M, Spears, M, Ludyga, N, Braselmann, H, Feuchtinger, A, Taylor, K J, Lindner, K, Auer, G, Stering, K, Höfler, H, Schmitt, M, Bartlett, J M S
Publicado 2010

What is the optimal systemic treatment of men with metastatic, hormone-naive prostate cancer? A STOPCAP systematic review and network meta-analysis

por Vale, C L, Fisher, D J, White, I R, Carpenter, J R, Burdett, S, Clarke, N W, Fizazi, K, Gravis, G, James, N D, Mason, M D, Parmar, M K B, Rydzewska, L H, Sweeney, C J, Spears, M R, Sydes, M R, Tierney, J F
Publicado 2018

Adding abiraterone or docetaxel to long-term hormone therapy for prostate cancer: directly randomised data from the STAMPEDE multi-arm, multi-stage platform protocol

por Sydes, M R, Spears, M R, Mason, M D, Clarke, N W, Dearnaley, D P, de Bono, J S, Attard, G, Chowdhury, S, Cross, W, Gillessen, S, Malik, Z I, Jones, R, Parker, C C, Ritchie, A W S, Russell, J M, Millman, R, Matheson, D, Amos, C, Gilson, C, Birtle, A, Brock, S, Capaldi, L, Chakraborti, P, Choudhury, A, Evans, L, Ford, D, Gale, J, Gibbs, S, Gilbert, D C, Hughes, R, McLaren, D, Lester, J F, Nikapota, A, O’Sullivan, J, Parikh, O, Peedell, C, Protheroe, A, Rudman, S M, Shaffer, R, Sheehan, D, Simms, M, Srihari, N, Strebel, R, Sundar, S, Tolan, S, Tsang, D, Varughese, M, Wagstaff, J, Parmar, M K B, James, N D
Publicado 2018